National Health Investors (NHI) Revenue (2009 - 2026)

National Health Investors has reported Revenue for 18 years, with the latest figure at $115.1 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue rose 28.93% year-over-year to $115.1 million; the trailing twelve-month figure through Mar 2026 stood at $256.3 million (up 26.77% YoY), and the FY2025 full-year result was $375.6 million, up 12.07% from the prior year.
• Revenue for Q1 2026 stood at $115.1 million, up from $105.8 million in the prior quarter.
• The five-year high for Revenue was $115.1 million in Q1 2026, with the low at -$171.7 million in Q4 2022.
• Historically, Revenue has averaged $38.2 million across 5 years, with a median of $21.2 million in 2025.
• Annual changes were most pronounced in 2022 — Revenue slumped 83.87% — and 2023, when it jumped 146.27%.
• National Health Investors' Revenue stood at -$171.7 million in 2022, then jumped by 146.27% to $79.5 million in 2023, then advanced by 7.92% to $85.8 million in 2024, then gained by 23.4% to $105.8 million in 2025, then advanced by 8.79% to $115.1 million in 2026.
• The last three Revenue figures came in at $115.1 million (Q1 2026), $105.8 million (Q4 2025), and $21.2 million (Q3 2025), per Business Quant data.